Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHARLES SWEET

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1164568283
CMS profile
233747
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$4,140.88

212 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,338.73 209
Consulting Fee $750.00 1
Education $52.15 2

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 5; records 101–150 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHARLES SWEET

NPI 1164568283 · CMS profile ID 233747

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1164568283?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHARLES SWEET, NPI 1164568283, CMS profile ID 233747. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1164568283?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). CHARLES SWEET, NPI 1164568283, CMS profile ID 233747. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1164568283?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
CHARLES SWEET, NPI 1164568283, CMS profile ID 233747, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 212 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1164568283?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

212 matching records · $4,140.88 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 212 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 212.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Supernus Pharmaceuticals, Inc. $3.8607/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953023019 CMS
JAZZ PHARMACEUTICALS INC. $750.0007/28/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951392111 CMS
Lundbeck LLC $6.0707/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945807525 CMS
Supernus Pharmaceuticals, Inc. $1.3407/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953023017 CMS
Neurocrine Biosciences, Inc. $20.8707/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963379571 CMS
Otsuka America Pharmaceutical, Inc. $7.2007/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929344525 CMS
Neos Therapeutics, LP $6.9607/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893151571 CMS
Teva Pharmaceuticals USA, Inc. $12.0407/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954718507 CMS
Alkermes, Inc. $12.5507/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953657 CMS
Alkermes, Inc. $1.8007/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953659 CMS
Alkermes, Inc. $1.7407/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953661 CMS
Alkermes, Inc. $6.2907/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953703 CMS
Sunovion Pharmaceuticals Inc. $42.4907/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921185577 CMS
Ironshore Pharmaceuticals Inc. $17.4607/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 958766449 CMS
Ironshore Pharmaceuticals Inc. $16.3006/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 958766443 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6.8806/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955846667 CMS
Otsuka America Pharmaceutical, Inc. $19.0606/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929344523 CMS
Alkermes, Inc. $0.7206/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953653 CMS
Alkermes, Inc. $0.2306/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953655 CMS
Alkermes, Inc. $17.9306/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953701 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.2806/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955846663 CMS
Neurocrine Biosciences, Inc. $24.3806/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963379455 CMS
ABBVIE INC. $10.9806/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892482743 CMS
Alkermes, Inc. $0.4606/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953645 CMS
Alkermes, Inc. $16.0506/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953647 CMS
Ironshore Pharmaceuticals Inc. $16.9705/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 958766447 CMS
Janssen Pharmaceuticals, Inc $15.9005/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886908153 CMS
Otsuka America Pharmaceutical, Inc. $7.0905/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929344521 CMS
Takeda Pharmaceuticals U.S.A., Inc. $111.2805/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955846659 CMS
Sunovion Pharmaceuticals Inc. $87.9705/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921185401 CMS
Alkermes, Inc. $77.6305/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953651 CMS
Sunovion Pharmaceuticals Inc. $26.9005/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921185643 CMS
Ironshore Pharmaceuticals Inc. $21.8205/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 958766457 CMS
Sunovion Pharmaceuticals Inc. $24.3705/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920957527 CMS
Alkermes, Inc. $21.1105/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925953649 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6.4905/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955846655 CMS
Ironshore Pharmaceuticals Inc. $17.5505/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 958766453 CMS
Supernus Pharmaceuticals, Inc. $15.9605/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953023015 CMS
ABBVIE INC. $24.0405/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892482741 CMS
Neurocrine Biosciences, Inc. $26.5705/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963379551 CMS
Otsuka America Pharmaceutical, Inc. $7.4405/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929344519 CMS
Neos Therapeutics, LP $7.8704/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893140547 CMS
Supernus Pharmaceuticals, Inc. $0.6204/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953023013 CMS
Supernus Pharmaceuticals, Inc. $6.4504/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953023011 CMS
Tris Pharma Inc $18.0904/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962097469 CMS
Supernus Pharmaceuticals, Inc. $0.3204/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953023009 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2.0704/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955846647 CMS
Takeda Pharmaceuticals U.S.A., Inc. $8.5504/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955846651 CMS
Ironshore Pharmaceuticals Inc. $9.0004/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 958766435 CMS
Corium, LLC $14.6104/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 924803759 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16,645.33 169
PY2020 $6,002.23 152
PY2021 $6,127.11 241
PY2022 $4,140.88 212
PY2023 $2,302.94 112
PY2024 $1,627.29 69
PY2025 $2,431.68 81

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $16,344.40 12
PY2023 Principal investigator $22,247.15 14
PY2022 Principal investigator $50,054.02 31
PY2021 Principal investigator $60,747.20 28
PY2020 Principal investigator $143,933.68 35
PY2019 Principal investigator $187,652.75 42

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 LivaNova USA, Inc. $1,700.00 08/03/2024 Non-covered Recipient Entity
BIOBEHAVIORAL RESEARCH OF AUSTIN PC
LivaNova UNCOVER No dispute reported 06/30/2026 1139457466
Principal investigator 1 LivaNova USA, Inc. $1,700.00 08/03/2024 Non-covered Recipient Entity
BIOBEHAVIORAL RESEARCH OF AUSTIN PC
LivaNova UNCOVER No dispute reported 06/30/2026 1139457568
Principal investigator 1 LivaNova USA, Inc. $1,700.00 08/03/2024 Non-covered Recipient Entity
BIOBEHAVIORAL RESEARCH OF AUSTIN PC
LivaNova UNCOVER No dispute reported 06/30/2026 1139457570
Principal investigator 1 Alkermes, Inc. $750.00 08/01/2024 Non-covered Recipient Entity
BIOBEHAVIORAL RESEARCH OF AUSTIN, P.C.
A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder No dispute reported 06/30/2026 1084816034
Principal investigator 1 LivaNova USA, Inc. $300.00 04/19/2024 Non-covered Recipient Entity
BIOBEHAVIORAL RESEARCH OF AUSTIN PC
LivaNova UNCOVER No dispute reported 06/30/2026 1139457468
Principal investigator 1 LivaNova USA, Inc. $2,730.00 03/12/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139457630
Principal investigator 1 LivaNova USA, Inc. $2,730.00 03/12/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139457982
Principal investigator 1 LivaNova USA, Inc. $295.00 02/06/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1139457944
Principal investigator 1 LivaNova USA, Inc. $295.00 02/06/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1139458711
Principal investigator 1 Alkermes, Inc. $3,554.40 01/25/2024 Non-covered Recipient Entity
BIOBEHAVIORAL RESEARCH OF AUSTIN, P.C.
A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder No dispute reported 06/30/2026 1084816032
Principal investigator 1 LivaNova USA, Inc. $295.00 01/04/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139457598
Principal investigator 1 LivaNova USA, Inc. $295.00 01/04/2024 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression No dispute reported 06/30/2026 1139457950